GTBP GT Biopharma Inc

USD 2.24 +0.11 ( +5.16%)
Icon

GT Biopharma Inc (GTBP) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.24

+0.11 (+5.16%)

USD 6.23M

0.03M

USD 11.00(+391.07%)

N/A

Icon

GTBP

GT Biopharma Inc (USD)
COMMON STOCK | NSD
USD 2.24
+0.11 ( +5.16%)
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 6.23M

N/A

USD 2.24

GT Biopharma Inc (GTBP) Stock Forecast

USD 11.00
(+391.07%)

Based on the GT Biopharma Inc stock forecast from 1 analysts, the average analyst target price for GT Biopharma Inc is USD 11.00 over the next 12 months. GT Biopharma Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of GT Biopharma Inc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, GT Biopharma Inc’s stock price was USD 2.24. GT Biopharma Inc’s stock price has changed by +2.28% over the past week, -6.28% over the past month and -40.59% over the last year.

No recent analyst target price found for GT Biopharma Inc
No recent average analyst rating found for GT Biopharma Inc

Company Overview GT Biopharma Inc

GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, ...Read More

https://www.gtbiopharma.com

8000 Marina Boulevard, Brisbane, CA, United States, 94005

2

December

USD

USA

Adjusted Closing Price for GT Biopharma Inc (GTBP)

Loading...

Unadjusted Closing Price for GT Biopharma Inc (GTBP)

Loading...

Share Trading Volume for GT Biopharma Inc Shares

Loading...

Compare Performance of GT Biopharma Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for GTBP

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To GT Biopharma Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +9.38 (+2.07%) USD118.90B 32.57 220.35

Frequently Asked Questions About GT Biopharma Inc (GTBP) Stock

Based on ratings from 1 analysts GT Biopharma Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.

Unfortunately we do not have enough data on GTBP's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for GTBP is USD 11.00 over the next 12 months. The maximum analyst target price is USD 11 while the minimum anlayst target price is USD 11.

Unfortunately we do not have enough data on GTBP's stock to indicate if its overvalued.

The last closing price of GTBP's stock was USD 2.24.

The most recent market capitalization for GTBP is USD 6.23M.

Based on targets from 1 analysts, the average taret price for GTBP is projected at USD 11.00 over the next 12 months. This means that GTBP's stock price may go up by +391.07% over the next 12 months.

We can't find any ETFs which contains GT Biopharma Inc's stock.

As per our most recent records GT Biopharma Inc has 2 Employees.

GT Biopharma Inc's registered address is 8000 Marina Boulevard, Brisbane, CA, United States, 94005. You can get more information about it from GT Biopharma Inc's website at https://www.gtbiopharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About GT Biopharma Inc (GTBP) Stock

Based on ratings from 1 analysts GT Biopharma Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.

Unfortunately we do not have enough data on GTBP's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for GTBP is USD 11.00 over the next 12 months. The maximum analyst target price is USD 11 while the minimum anlayst target price is USD 11.

Unfortunately we do not have enough data on GTBP's stock to indicate if its overvalued.

The last closing price of GTBP's stock was USD 2.24.

The most recent market capitalization for GTBP is USD 6.23M.

Based on targets from 1 analysts, the average taret price for GTBP is projected at USD 11.00 over the next 12 months. This means that GTBP's stock price may go up by +391.07% over the next 12 months.

We can't find any ETFs which contains GT Biopharma Inc's stock.

As per our most recent records GT Biopharma Inc has 2 Employees.

GT Biopharma Inc's registered address is 8000 Marina Boulevard, Brisbane, CA, United States, 94005. You can get more information about it from GT Biopharma Inc's website at https://www.gtbiopharma.com.
Loading...